FMP
Jan 22, 2026
CACI International Inc (NYSE:CACI) is a prominent player in the information technology sector, providing services and solutions to government and commercial clients. The company is known for its expertise in defense, intelligence, and cybersecurity. CACI competes with other major firms in the industry, such as Leidos and Booz Allen Hamilton, offering a range of IT services and solutions.
On January 22, 2026, Tobey Sommer from Truist Financial set a new price target for CACI at $800. At the time, CACI's stock was priced at $654.36, suggesting a potential upside of 22.26%. This optimistic outlook reflects confidence in CACI's strategic direction and financial performance, as discussed in their recent Q2 2026 earnings call.
The Q2 2026 earnings call, hosted by Seeking Alpha, is a crucial event for investors. It provides insights into CACI's financial health and strategic plans. Although the full transcript is not available, such calls typically cover revenue growth, profit margins, and significant contracts. These factors are essential for understanding CACI's market position and future prospects.
CACI's stock has shown a positive trend, with a 3.45% increase, or $21.80, reaching $654.36. The stock fluctuated between $622.05 and $661.99 today, with the latter marking its highest price over the past year. This performance indicates strong investor interest and confidence in CACI's growth potential.
With a market capitalization of approximately $14.45 billion and a trading volume of 595,707 shares, CACI is a significant player in the market. The company's ability to secure substantial contracts and maintain a competitive edge in the IT sector is crucial for sustaining its growth and achieving the $800 price target set by Truist Financial.
Corcept Therapeutics Incorporated (NASDAQ:CORT) is a pharmaceutical company focused on developing medications that modul...
CRISPR Therapeutics AG (NASDAQ:CRSP) is a biotechnology company focused on developing transformative gene-based medicine...